home / stock / sva:cc / sva:cc news


SVA:CC News and Press, Sernova Corp.

Stock Information

Company Name: Sernova Corp.
Stock Symbol: SVA:CC
Market: TSXVC
Website: sernova.com

Menu

SVA:CC SVA:CC Quote SVA:CC Short SVA:CC News SVA:CC Articles SVA:CC Message Board
Get SVA:CC Alerts

News, Short Squeeze, Breakout and More Instantly...

SVA:CC - Sernova to amend warrants, extend expiry, and cut exercise price

2026-02-20 07:56:39 ET More on Sernova Biotherapeutics Inc Seeking Alpha’s Quant Rating on Sernova Biotherapeutics Inc Historical earnings data for Sernova Biotherapeutics Inc Financial information for Sernova Biotherapeutics Inc Read the full articl...

SVA:CC - Sernova Biotherapeutics Announces Warrant Amendments

Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - February 20, 2026) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSH0) ("the Company"), a leading regenerative medicine company focused on developing its Cell Pouch Bio-hybrid Organ as a functional cure for type 1 d...

SVA:CC - From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes

VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- USA News Group News Commentary – Stanford researchers achieved complete diabetes reversal in mice using a combined blood stem cell and islet transplant that eliminates the need for insulin or immunosuppressive d...

SVA:CC - Sernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical Efforts

Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - November 13, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSH) ("Sernova or the Company)") a leading regenerative medicine company focused on developing its Cell Pouch Bio-hybrid Organ as a functional cure fo...

SVA:CC - Sernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang

Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - October 1, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTCQB: SEOVF) (FSE: PSH0) ("Sernova") a leading regenerative medicine company focused on developing its Cell Pouch Bio-hybrid Organ as a functional cure for type 1 diabet...

SVA:CC - Sernova Biotherapeutics Appoints John L. Brooks III, Former Chair and CEO of Joslin Diabetes Research Center, as Chair of the Board of Directors

(TheNewswire) TORONTO and BOSTON - September 22, 2025 - The Newswire — Sernova Biotherapeutics (“Sernova”) (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) a leading regenerative medicine company focused on developing its Cell Pouch Bio-hybrid Organ as a functional cu...

SVA:CC - Expected Canadian Company Earnings on Monday, September 15th, 2025

Evome Medical Technologies Inc. (EVMT:CA) is expected to report for quarter end 2025-06-30 High Tide Inc. (HITI:CA) is expected to report $0 for Q3 2025 Sernova Biotherapeutics Inc. (SVA:CA) is expected to report for Q3 2025

SVA:CC - Sernova Biotherapeutics to Participate in the H.C. Wainwright 27th Annual Global Investor Conference

(TheNewswire) London, Ontario – TheNewswire - September 8 , 2025 - Sernova Biotherapeutics (“Sernova”) (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) a leading regenerative medicine company focused on developing its Cell Pouch Bio-hybrid Organ as a functiona...

SVA:CC - Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes

LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics (“Sernova”) (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research Agreement with Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) to evaluate Eledon’s ...

SVA:CC - Expected Canadian Company Earnings on Friday, June 13th, 2025

Sernova Biotherapeutics Inc. (SVA:CA) is expected to report for Q2 2025 Moovly Media Inc. (MVY:CA) is expected to report for quarter end 2025-03-31 BriaCell Therapeutics Corp. (BCT:CA) is expected to report $-2.43 for Q3 2025 Santacruz Silver Mining Ltd. (SCZ:CA) is expected to report...

Next 10